Category Archives: The List

Curtains For Biotech?

November 27, 2024 By in $SPSIBI, Biotech, Holiday Turns, LABD, SPBIO, The Daily Sceptic, The List, The Speck, XBI, XBI-24-01 Tags: , , 1 Comment

Today, Is ‘Day 13’

Strange things happen in the markets just before, during, or just after a holiday week.

This time is no different.

With all that’s gone on in the past few weeks, one gets a sense ‘the jig is up’.

One example of the curtain being pulled back on a well-established grift, is this unrelated, but related post, link here.

So, it could be with biotech.

The past two weeks look like a change of character (not advice, not a recommendation).

Biotech XBI, Daily

It’s been a Fibonacci 13-Days since the reversal on 11/11.

The sector has accelerated to the downside on record volume and now, is testing that break.

The ‘Axis Line’, is also the location of the 61.8%, retrace for the current down-move and test.

Although there’s been no new daily low to ‘confirm’ the test is complete, (upside) risk may be at a low.

Positioning

For reasons to be covered in a later update, this sector’s being shorted directly as opposed to using leveraged inverse LABD (not advice, not a recommendation).

Trade is labeled: XBI-24-01

Stop level for the short is (or will be) the session high, currently at XBI 99.79 (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

‘Free-Fall’, For Biotech … Closer

October 12, 2023 By in $SPSIBI, Biotech, LABD-23-10, LABD-23-11, Positions, SPBIO, The List, ZeroHedge 2 Comments

Downside Pressure Builds

With this session’s price action continuing lower, getting back into the short trade (via LABD) was the correct move (not advice, not a recommendation).

With that said, we’re nearing the dangerous part.

Downside pressure continues to build.

As the chart shows, SPBIO ($SPSIBI) is close to the point where there’s no more support until much lower levels.

Biotech SPBIO ($SPSIBI), Daily

The Blue arrows highlight short entries (via LABD).

Short No. 1 was subsequently stopped out yesterday, then re-established (the same day) at the next arrow, No. 2.

If and when price action gets to the ‘free-fall’ area, anything can happen.

We could bounce off the support level, hover at it, or slice straight through.

Positioning

It’s obvious this sector’s in trouble. The fundamentals continue to build.

Just a few days after this post we have two more to add to ‘The List’, here and here.

Yesterday’s post showed a not-so-good entry that at this point in today’s session, has been ‘healed’ by price action.

We’re well above that (LABD 21.69) entry and solidly in the green (not advice, not a recommendation).

The stop on the LABD-23-11, position is now being moved (tentatively) higher at today’s low of, LABD 22.01.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech (Short) Trade Update

October 9, 2023 By in $SPSIBI, Biotech, LABD, LABD-23-10, Positions, SPBIO, The List, ZeroHedge 2 Comments

Behind The Scenes, Biotech Verifies Trend

Hardly a day goes by where we don’t get some kind of biotech ‘conspiracy’ or exposé like this, this, this, or this.

True or not, from a trading standpoint, we’re interested in reality.

So far, that reality, i.e., the price action, says that out of all the major sectors (except bonds, perhaps), biotech, and specifically, SPBIO ($SPSIBI) is the weakest (not advice, not a recommendation).

The Trade With No Name

Since the existing short on biotech via LABD is solidly in the green (original entry @ 16.99), it’s going to be tracked on this site as LABD-23-10, indicating the tenth series (trade campaign) this year.

Biotech SPBIO, 3X Leveraged Inverse LABD, Daily

The first chart shows the original entry (documented here and here) and the stop progression.

The second chart shows that we’re in a trading channel, confirmed with today’s higher (daily) high, with SPBIO, lower.

During this session, the stop has been tightened up to LABD 20.74 (Friday’s low).

With that, it could all be over soon, i.e., getting stopped out; or, it’s just a continuing series of well-disciplined progressions protecting open profit (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

When Costco Sells Gold

October 1, 2023 By in China, Food Supply, Genesis 41, GLD, GOLD, Gold & Silver, Gold Miners, serpentza, The List, The Speck, Wyckoff, ZeroHedge

The Mother of All Contrary Indicators

This has to be it, right?

Selling gold in a supermarket; an expensive commodity, peddled to the least informed and least capitalized segment of the public.

Once that market’s saturated, who’s left?

Going Down Memory Lane

It’s been nearly three years since this post.

From a long-term strategy standpoint, this site has been consistent; it’s the food supply first, then gold and silver (not advice, not a recommendation).

The next shoe has yet to drop on how or what’s going to be used to extract (or confiscate) precious metals from the (stacking) proletariat.

With craziness by the day, anything can happen.

Gold: Turning Points & Technical

So far, it’s been three-for-three (here, here and here) identifying recent significant technical conditions and turning points for gold, GLD.

At this juncture, the dollar collapse, and the silver/gold bull launch are just not happening. It’s not there … something else is going on (not advice, not a recommendation).

We’re in the middle of a massive sovereign bankruptcy (Time Stamp 7:10) that’s never happened before.

What’s going on behind the scenes is not visible to us.

However, from a Wyckoff analysis standpoint, those (hidden) actions and decisions show up on the chart(s).

Contrary Indicator

Remember Baghdad Bob?

Constantly giving press conferences discussing the strength of the military campaign when the exact opposite was true.

It may be so with gold as well (not advice, not a recommendation).

The local supermarket has decided, after a 22-year long bull market, it’s ‘safe’ for profit.

The hapless public is now standing at the gold kiosk; with face-mask firmly secured, arm bandaged from the latest booster, EV FOB in hand (or pocket), hypnotized into yet another mania.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech Sector, Buckles

September 28, 2023 By in $SPSIBI, Biotech, LABD, Positions, SPBIO, Speck-Effect, The List, The Speck, ZeroHedge 1 Comment

Bad, And More Bad News

It’s been a little nerve-wracking over the past two sessions being short biotech; was it an upward correction, or a full-blown reversal?

No one really knows, until it’s over.

Well, as of today’s new daily low in index SPBIO, it looks like what is now seen as a correction, may be complete (not advice, not a recommendation).

Bad, And More Bad

On the fundamental side, The List keeps building with links like this, this and this.

However, keep in mind, it may be something as simple as rising interest rates that’s ultimately going to collapse biotech and the rest of the markets (not advice, not a recommendation).

Moving on and looking at the chart of SPBIO, there’s a trend confirmation and potential trading channel.

Biotech SPBIO, Daily

The left side line is the trend … the right-side line is what’s called the ‘reverse trendline’ and possibly defines the trading channel.

As of this post (12:30 p.m., EST) the SPBIO, is doing all it can to reverse higher, against what may be the over-riding (down) trend.

So far, the daily high of SPBIO 5764.73, remains intact.

Positioning

As a result of today’s new SPBIO low, the stop has been moved on the position in the inverse fund LABD, from LABD 18.22, to LABD 19.18 (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Good News, Bad News … Biotech

September 19, 2023 By in $SPSIBI, 1907, Biotech, LABD, Livermore, Positions, SPBIO, The List, Wyckoff 4 Comments

When Price Action Heads South

One of the first things a professional (mentor) will teach aspiring traders, is:

‘Big money potential is on the downside’.

A famous example of this, was during the Panic of 1907,

Jesse Livermore raised capital by hawking his car for $5,000 (according to Wyckoff), then shorted the market.

Near the bottom on (or about) October 24th, 1907, he covered; netting over $1 million in profits.

That Was Then … Is That Now?

Well, conditions change, but human behavior does not.

Back in the day, it was newspapers, telephone, telegraph and ‘rumors’; today, we have Cramer 🙂

You’ll have to judge for yourself if the posts on this site are providing worthwhile insight.

Let’s move on to Biotech, SPBIO.

Since I am short this sector via LABD (not advice, not a recommendation), we’re going to look at that vehicle.

Biotech Leveraged Inverse LABD, Daily

After the entry on 9/14, at 16.99, price action has not looked back.

Note, the entry had a very tight stop as covered here.

The ‘risk’ is determined as the distance from entry to stop; in the case above, 16.99 – 16.66 = 0.33-pts.

For example, a ‘risk’ of $1,000 let’s say, equates to a position size just over 3,000 shares LABD (not advice, not a recommendation).

Trending

The chart shows LABD, is currently trending higher at an aggressive rate.

There’s no guarantee this will continue to hold.

However, at the same time, there’s been no ‘news generating’ breakout, either.

So, at this point, it’s all under the radar.

Bad News Comes Out

When price action heads south, bad news comes out.

On a daily basis now, with articles like this and this.

Positioning

The initial position has already been discussed.

Other minor ones have been opened but the more important part, is Stop placement.

The initial Stop has been moved from LABD 16.66 to yesterday’s low of LABD 17.59 (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Fibonacci, Force and Biotech

July 12, 2023 By in $SPSIBI, LABD, Positions, SPBIO, The List, The Speck, Wyckoff, ZeroHedge

Waiting For The ‘Event Horizon’

We’re going to start first, with this link, presenting the on-going fundamentals of the sector.

For those of us literally pulling their hair out, wondering if the dam is ever going to break, we have this link.

‘We’ve just poisoned 5-Billion people …’

Note: The dam break is the ‘event horizon’ where everyone collectively wakes-up. Once that happens, the ‘conspiracy’ has been proven as undeniable fact.

Biotech SPBIO, may or may not have an absolute direct connection with the aforementioned links but it’s the ‘baby with the bathwater’ response that’s expected.

Adding to that, big players in this sector have no P/E

The top-ten weightings keep changing, but the last time it was checked, none in the top-ten, had a P/E.

Since we’re working the short side, it’s the leveraged inverse fund LABD that’s of interest.

Biotech Leveraged Inverse LABD, Daily

Note the near perfect Fibonacci time correlation.

As of today’s close, price action on the LABD has got itself into a Wyckoff ‘spring position’ having decisively penetrated support (blue line), shown below.

That spring set-up has been accomplished on weak down-thrust when compared to the prior move lower.

We have a high probability of upside reversal, down for SPBIO (not advice, not a recommendation).

Positioning

Stated in the prior update, we’re short this sector (long LABD) and now have Hard Stop @ LABD 13.27 (not advice, not a recommendation).

Update: 7/13/23, 2:51 p.m. EST

LABD price action pushed to 13.26, just 0.01, below the above listed stop and is now moving higher.

Trade has been maintained (not advice, not a recommendation)

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Is Biotech (Short) Back?

July 10, 2023 By in $SPSIBI, Biotech, LABD, Positions, SPBIO, The List, The Speck, Wyckoff, ZeroHedge

First, The SOXX Housekeeping

Biotech Sector SPBIO ($SPSIBI) has got itself into a Wyckoff Up-Thrust (reversal) condition but first, we’ll update the SOXS trade.

A discretionary exit was made during this session at SOXS 10.10, for just over 1% profit (not advice, not a recommendation).

The trade was in the green and not going to be allowed to go red … a simple, but difficult to execute, trading rule.

We’re still in a bubble. That has not changed. So, it’s being watched closely.

Meanwhile, biotech SPBIO ($SPSIBI) reversed on June 14th and has been edging lower ever since. Today, we have what looks to be an up-thrust condition.

Price action has penetrated previous resistance and stalled (thus far).

Since our interest is to short the sector, we’ll go straight to the leveraged inverse fund LABD.

Biotech SPBIO, Leveraged Inverse LABD, Hourly

With about an hour before the close, price action’s penetrated support and has slowed significantly.

Positioning:

LABD entry @ 13.8766; Soft-Stop and Hard-Stop might be at the lows for the day (not advice, not a recommendation). More on that, later.

Fundamentals

The drivers for potential downside continue to grow.

Scenes like this have now entrenched themselves into the public arena.

As stated, many times (in the opinion of this author), these events are the primary driving force for all market activity on a go forward basis.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Supply & Demand … Junior Miners

June 29, 2023 By in GDXJ, Gold & Silver, Gold Miners, JDST, Positions, serpentza, The List, The Speck 1 Comment

Testing The Right-Side

It’s a good thing we’re not listening to the ‘inflation’ narrative, just like we didn’t listen to ‘The Speck’ narrative of the past few years.

Turns out, ‘The Speck‘ was just the re-branded, common flu.

Inflation or Deflation

One has to wonder if the mainstream will ever acknowledge we’re in a deflation impulse.

The ‘inflation’ we’re seeing is (potentially) more associated with supply, product, and population destruction than any ‘money printing’ (not advice, not a recommendation).

As ‘Winston’ says at this link (time stamp (1:21:48),

‘People are allergic to the truth.’

The truth for the day, concerning the Junior Mining Index GDXJ, is that we’re testing the right-side trend line, the supply side.

Junior Miners GDXJ, Daily Candle

Today’s price action is technically a ‘Key reversal’.

As such, the typical response is continuation to the upside during the coming days and or weeks.

Key reversals are not perfect and at times, will fail.

The important session for GDXJ, is tomorrow, Friday.

Continued upside most likely results in exit of short positions (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Key Reversal … Yet Again

June 13, 2023 By in 1987, DUST, Federal Reserve, GDX, GDXJ, Gold & Silver, Gold Miners, IYR, JDST, Real Estate, The List, The Maverick of Wall Street, The Speck 2 Comments

Junior Miners Take Another Hit

With today’s outside-down (as of 2:43 p.m., EST), that makes it two key reversals for GDXJ, in the past five trading days.

While it looks like the whole herd is focused on the new mania, Artificial Intelligence, back at the ranch, the miners are painting an ominous picture.

Rendezvous With Destiny

The first two-minutes and ten seconds, at this link, are all that’s needed to get the idea of what’s likely to come.

The market recovered (fairly quickly) from 1987 … this time, may indeed be different.

The Elephant Sleeps

Ah, yes. The elephant no one talks about … or more accurately, are afraid to talk about.

Three links here, here and here, show us the elephant may be about to awake.

Even Fox News admits, it was all a lie.

Junior Miners GDXJ, Trend & Channel

From the bottom, May 25th to now, is a Fibonacci 13-Days.

Is that important?

Here’s a prior analysis on Real Estate IYR, that shows how Fibonacci can identify the pivot point, trend and/or trading channel.

Now, back to the Juniors.

The mining sector appears to be under pressure. Each attempt to rally is being thwarted.

Compressed view of the channel, below.

The Fed announcement at 2:00 p.m., EST tomorrow, may or may not have any material effect. The sector may just continue lower …. slowly, without much fanfare (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279